CORONA, Calif., May 13 /PRNewswire-FirstCall/ -- Watson Pharmaceuticals, Inc. , a leading specialty pharmaceutical company, announced today that management will host and webcast a meeting for the investment community at the American Urological Association (AUA) Annual Meeting taking place in Orlando, Florida May 17-22, 2008.
The company will be hosting the meeting to provide an overview of its Brand business and to review data presented on two new studies:
The event will be held on Tuesday May 20, 2008 from 3:30 p.m. to 5:00 p.m. Eastern Daylight Time at The Peabody Orlando Hotel, 9801 International Drive, Mezzanine Level, Bayhill Suite 2, Orlando, FL. To participate in the event in person, please RSVP to Patty Eisenhaur, Executive Director, Investor Relations by Friday, May 16th at 951.493.5611.
The presentation will be webcast live and can be accessed on Watson Pharmaceuticals' Investor Relations Web site at http://ir.watson.com or at http://phx.corporate-ir.net/phoenix.zhtml?p=irol- eventDetails&c=65778&eventID=1848531. Pre-registration is not required to view the webcast. An archived version will be available for 30 days after the live presentation and can be accessed at the same location.
About Watson Pharmaceuticals, Inc.
Watson Pharmaceuticals, Inc, headquartered in Corona, California, is a leading specialty pharmaceutical company that develops, manufactures, markets, sells and distributes brand and generic pharmaceutical products. Watson pursues a growth strategy combining internal product development, strategic alliances and collaborations and synergistic acquisitions of products and businesses.
For press releases and other company information, visit Watson Pharmaceuticals' Web site at http://www.watson.com.
CONTACT: Patty Eisenhaur of Watson Pharmaceuticals, Inc., +1-951-493-5611
Web site: http://www.watson.com/
http://ir.watson.com/